A new Eli Lilly experimental drug has helped patients lose 24 percent of their weight, according to new mid-stage clinical trial results. The results, released on Monday, followed 338 adults, nearly 52 percent of whom were men, who were obese or overweight and had either received Eli Lilly’s retatrutide injection or a placebo treatment. Eli…

Related Keywords

Eli Lily , Eli Lilly , Body Weight , Placebo Treatment , Decreased Appetite , Experimental Drug , Obesity Drug ,